Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group [letter]

Kay, NE; Oken, MM; Bone, N; Kyle, RA; Greipp, P; Van Ness, B; Leong, T

doi:10.1182/blood.V86.10.4000.bloodjournal86104000

NE Kay,

NE Kay

Search for other works by this author on:

This Site

PubMed

Google Scholar

MM Oken,

MM Oken

Search for other works by this author on:

This Site

PubMed

Google Scholar

N Bone,

N Bone

Search for other works by this author on:

This Site

PubMed

Google Scholar

RA Kyle,

RA Kyle

Search for other works by this author on:

This Site

PubMed

Google Scholar

P Greipp,

P Greipp

Search for other works by this author on:

This Site

PubMed

Google Scholar

B Van Ness,

B Van Ness

Search for other works by this author on:

This Site

PubMed

Google Scholar

T Leong

Search for other works by this author on:

This Site

PubMed

Google Scholar

Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group [letter]

Article PDF first page preview

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology

Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group [letter]

Article PDF first page preview

Contents

Data & Figures

Supplemental data

References

Related

Related

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only